The NF-κB signaling pathway is activated in the TME and contains 49 DEGs, 35 of which displayed higher expression in the TME and 14 with higher expression in the HCC tumors (Figure 5). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.